$0.13
Zomedica Pharmaceuticals is a medical devices business based in the US. Zomedica Pharmaceuticals shares (ZOM) are listed on the NYSE MKT and all prices are listed in US Dollars. Zomedica Pharmaceuticals employs 144 staff and has a trailing 12-month revenue of around $26.1 million.
Our top picks for where to buy Zomedica Pharmaceuticals stock
How to buy Zomedica Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ZOM. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Zomedica Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Zomedica Pharmaceuticals stock price (NYSE MKT: ZOM)
Use our graph to track the performance of ZOM stocks over time.Zomedica Pharmaceuticals shares at a glance
Latest market close | $0.12 |
---|---|
52-week range | $0.12 - $0.23 |
50-day moving average | $0.15 |
200-day moving average | $0.15 |
Wall St. target price | $0.44 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.06 |
Is it a good time to buy Zomedica Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Zomedica Pharmaceuticals price performance over time
Historical closes compared with the close of $0.1232 from 2024-09-04
1 week (2024-08-29) | -2.99% |
---|---|
1 month (2024-08-05) | -17.92% |
3 months (2024-06-05) | -21.28% |
6 months (2024-03-05) | -12.00% |
1 year (2023-09-05) | -33.41% |
---|---|
2 years (2022-09-02) | -45.89% |
3 years (2021-09-03) | 0.6 |
5 years (2019-09-05) | 0.412 |
Zomedica Pharmaceuticals financials
Revenue TTM | $26.1 million |
---|---|
Gross profit TTM | $13.7 million |
Return on assets TTM | -9.29% |
Return on equity TTM | -23.92% |
Profit margin | -214.7% |
Book value | $0.21 |
Market Capitalization | $128.6 million |
TTM: trailing 12 months
Zomedica Pharmaceuticals share dividends
We're not expecting Zomedica Pharmaceuticals to pay a dividend over the next 12 months.
Zomedica Pharmaceuticals share price volatility
Over the last 12 months, Zomedica Pharmaceuticals's shares have ranged in value from as little as $0.12 up to $0.2285. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Zomedica Pharmaceuticals's is 1.03. This would suggest that Zomedica Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Zomedica Pharmaceuticals overview
Zomedica Corp. , a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system.
Frequently asked questions
What percentage of Zomedica Pharmaceuticals is owned by insiders or institutions?Currently 1.77% of Zomedica Pharmaceuticals shares are held by insiders and 8.622% by institutions. How many people work for Zomedica Pharmaceuticals?
Latest data suggests 144 work at Zomedica Pharmaceuticals. When does the fiscal year end for Zomedica Pharmaceuticals?
Zomedica Pharmaceuticals's fiscal year ends in December. Where is Zomedica Pharmaceuticals based?
Zomedica Pharmaceuticals's address is: 100 Phoenix Drive, Ann Arbor, MI, United States, 48108 What is Zomedica Pharmaceuticals's ISIN number?
Zomedica Pharmaceuticals's international securities identification number is: CA98980M1095 What is Zomedica Pharmaceuticals's CUSIP number?
Zomedica Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 98979F107
More guides on Finder
-
Options profit calculator
Use this calculator to quickly see potential outcomes of your options trades.
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 E*TRADE competitors worth your time
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
-
Charles Schwab vs. Fidelity
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question